🇺🇸 FDA
Company

LB

LB PHARMACEUTICALS INC

LBRX pharma USA

Quick answer

LB is a pharma company (LBRX) headquartered in NEW YORK, NY, USA with 3 tracked pipeline programs.

Pipeline (3)

project

LB-102

Schizophrenia

Phase 3 · small_molecule · active

4 trials project

LB-102 (50 mg tablet)

Schizophrenia

Phase 3 · small_molecule · active

1 trials project

LB-102

Bipolar I Disorder

Phase 2 · small_molecule · active

1 trials

Patents (7)

patent

US 12060327

Psychotropic agents and uses thereof

Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11713295

Psychotropic agents and uses thereof

Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11377421

Psychotropic agents and uses thereof

Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11040943

Psychotropic agents and uses thereof

Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10689338

Psychotropic agents and uses thereof

Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10259786

Psychotropic agents and uses thereof

Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10167256

Psychotrophic agents and uses thereof

Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)